Email Updates

You are here

Home

19 JANUARY 2018 VOLUME 19 ISSUE 3

Media Coverage

  • HIV orgs must do more than testing in age of Trump

    In the era of Trump, HIV organizations can no longer sit on the sidelines fearful of jeopardizing their 501(c)3 non-profit status by becoming politically involved….Testing, linkage to care, treatment as prevention, PrEP, and all of the other services these organizations offer to our communities won’t mean much if this president is successful in dismantling every program, agency, and pot of money we rely on to keep people healthy.

    January 18, 2018
    General
    Washington Blade

  • Many gay men believe effective HIV treatment blocks transmission

    In a recent large survey of this population, more than half of the HIV-negative men and one third of the HIV-positive respondents perceived the “Undetectable = Untransmittable” slogan as inaccurate.

    January 17, 2018
    Treatment
    POZ

  • People with HIV take note: This year's flu strain can be dangerous, especially for elders

    Although there's no evidence that that this year's flu is hitting older people with HIV harder than others, there's ample reason for older people with HIV to be cautious.

    January 17, 2018
    General
    The Body

  • CityViews: Gov. Cuomo must recommit to the fight to end AIDS

    Governor Cuomo has continued to speak in favor of ending AIDS during each of his annual State of the State addresses starting in 2015. But this month at the same address,… the Governor didn’t mention HIV or AIDS once, and we heard a painful reminder of that silence that has caused the deaths of so many.

    January 17, 2018
    General
    City Limits

  • Aetna customers get $17 million in HIV privacy settlement

    After thousands of customers' HIV statuses were revealed in mailings last year, a federal class-action lawsuit against health care company Aetna has reached a $17 million settlement. The lawsuit was filed in August after some 12,000 Aetna customers nationwide received letters mailed in July that accidentally revealed their HIV status through the windows of the envelopes, indicating they were taking either HIV medications or PrEP, a pre-exposure prophylactic that prevents HIV.

    January 17, 2018
    General
    CNN

  • Long-acting injectable ARVs are convenient and private, study participants report

    HIV-positive people who took injectable cabotegravir + rilpivirine every four or eight weeks as antiretroviral therapy found it more convenient and discreet than daily pills, also feeling that it eliminated a “daily reminder of living with HIV”, Deanna Kerrigan and colleagues report in PLOS One.

    January 17, 2018
    PrEP, Treatment
    aidsmap

  • Drop my body on the steps of the FDA: Death, queer activism & advocacy during the HIV/AIDS crisis

    This article is my attempt to help younger people, and anyone else who may not have the information, understand why AIDS became the fearful epidemic that it was and the role death played in the fight to change how AIDS victims were treated.

    January 16, 2018
    General
    Dead Maidens

  • The Atlanta HIV epidemic that remains

    HIV in Atlanta has steadily climbed to reach an epidemic level on par with developing countries and isn’t getting any better. Earlier this summer, Dr. Carlos del Rio, co-director of Emory University’s Center for AIDS Research, told the Atlanta Journal-Constitution that HIV levels of Downtown Atlanta were “as bad as Zimbabwe or Harare or Durban.”

    January 16, 2018
    General
    The Signal

  • Gilead will help fund the fight against HIV in southern states. Is that a mixed blessing?

    Gilead -- whose HIV treatment and prevention blockbuster pill Truvada (tenofovir/FTC) accounted for about 10% of the drugmaker's $30 billion in sales in 2016 --announced it was launching The COMPASS Initiative, a 10-year, 100-million dollar commitment to supporting organizations fighting the HIV epidemic in the hard-hit, underfunded American South.

    January 16, 2018
    PrEP
    The Body

  • HIV self-testing kits got lukewarm reception: official

    Close to 500,000 Kenyans still did not know their HIV status, and many are reluctant to visit testing clinics.

    January 16, 2018
    General
    Nation

  • Mathilde Krim, mobilizing force in an AIDS crusade, dies at 91

    Mathilde Krim, who crusaded against the scourge of AIDS with appeals to conscience that raised funds and international awareness of a disease that has killed more than 39 million people worldwide, died on Monday at her home in Kings Point, N.Y. She was 91.

    January 16, 2018
    General
    New York Times

  • Kenyan health advocates reach out to women to boost war against HIV/AIDS

    Sixty-nine year old Kenyan Josephine Naliaka lost one of her daughters to HIV/AIDS two years ago. Her another daughter, who is currently bed-ridden, could succumb to the same disease in the near future.

    January 15, 2018
    PrEP
    Xinhua

  • Oregon scientist develops promising vaccine against tuberculosis

    An Oregon scientist has developed a vaccine against tuberculosis that appears to be highly effective against the devastating disease. The vaccine reduced tuberculosis infections by 70 percent in rhesus monkeys, according to a paper published Monday in the journal Nature Medicine.

    January 15, 2018
    General
    Oregon Live

  • Attitudes towards men who ‘bareback’ are a barrier to wider use of PrEP

    Two new qualitative studies from Toronto shed light on how stigma affects the uptake of pre-exposure prophylaxis (PrEP) and the experience of taking it. In the first, young gay men acknowledged that they did not always use condoms but did not see themselves as the kind of ‘barebacker’ for whom they thought PrEP was intended.

    January 15, 2018
    PrEP
    aidsmap

  • HIV activists prepare for what lies ahead in 2018

    In the past year, health advocacy in the U.S. was a real stressor…A lot was at stake…. But advocates working in Washington, D.C., haven't rested on their laurels. They're continuing to plan for what Congress and the administration have in store for the upcoming year.

    January 15, 2018
    General
    The Body

  • Powerful HIV-neutralizing response possible in most people, study by San Diego researchers finds

    In an advance toward an effective HIV vaccine, San Diego researchers have shown how cells vital to stopping the virus can be made to multiply. The study will help guide upcoming vaccine trials.

    January 14, 2018
    HIV Vaccine
    San Diego Tribune

Published Research

Announcements